Pharma Partnerships Boost Biotechs; Top Drug Stocks See Volatile Week
-
Eli Lilly and Isomorphic Labs team up to discover small molecule therapeutics for multiple targets. Isomorphic gets $45M upfront and up to $1.7B in milestones.
-
Novartis-Isomorphic collaboration to find small molecule therapeutics vs. 3 targets. Isomorphic gets $37.5M upfront plus possible $1.2B in milestones.
-
Eli Lilly stock jumped 6.1% last week, clearing entries and briefly topping a 629.97 buy point.
-
NVS stock rose 5.3% last week to 106.31, extended from a 98.69 double-bottom buy point.
-
GOOGL stock fell 2.8% to 135.73, dropping below a 139.42 cup-with-handle buy point.